The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-03-07
DOI
10.1007/s00259-021-05253-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease
- (2021) Joel Simrén et al. Alzheimers & Dementia
- Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology
- (2021) Nicholas J. Ashton et al. ACTA NEUROPATHOLOGICA
- 2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework
- (2021) A. Leuzy et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The strategic biomarker roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update
- (2021) Marina Boccardi et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer’s Disease Multimodal Biomarker Discovery Cohort
- (2020) Sarah Westwood et al. JOURNAL OF ALZHEIMERS DISEASE
- Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia
- (2020) Shorena Janelidze et al. NATURE MEDICINE
- Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration
- (2020) Elisabeth H. Thijssen et al. NATURE MEDICINE
- Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
- (2020) Thomas K Karikari et al. LANCET NEUROLOGY
- Nanoparticle-based immunomagnetic assay of plasma biomarkers for differentiating dementia and prodromal states of Alzheimer's disease – A cross-validation study
- (2020) Ming-Jang Chiu et al. Nanomedicine-Nanotechnology Biology and Medicine
- A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease
- (2020) Nicolas R. Barthélemy et al. NATURE MEDICINE
- An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders
- (2020) Nicholas J. Ashton et al. Nature Reviews Neurology
- Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease
- (2020) Shorena Janelidze et al. Nature Communications
- Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification
- (2020) Nicolas R. Barthélemy et al. Alzheimers Research & Therapy
- Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer’s disease
- (2020) Niklas Mattsson-Carlgren et al. Science Advances
- Plasma p-tau181 accurately predicts Alzheimer’s disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline
- (2020) Juan Lantero Rodriguez et al. ACTA NEUROPATHOLOGICA
- Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
- (2020) Sebastian Palmqvist et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer’s disease
- (2020) Nicolas R. Barthélemy et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Diagnostic and prognostic value of serum NfL and p-Tau181 in frontotemporal lobar degeneration
- (2020) Alberto Benussi et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Plasma phospho-tau181 in presymptomatic and symptomatic familial Alzheimer’s disease: a longitudinal cohort study
- (2020) Antoinette O’Connor et al. MOLECULAR PSYCHIATRY
- Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19
- (2020) Nelly Kanberg et al. NEUROLOGY
- Sex differences in CSF biomarkers vary by Alzheimer’s disease stage and APOE ε4 genotype
- (2020) Rosha Babapour Mofrad et al. NEUROLOGY
- Remote Blood Biomarkers of Longitudinal Cognitive Outcomes in a Population Study
- (2020) Kumar B. Rajan et al. ANNALS OF NEUROLOGY
- Plasma NT1 Tau is a Specific and Early Marker of Alzheimer's Disease
- (2020) David Mengel et al. ANNALS OF NEUROLOGY
- Longitudinal plasma p-tau217 is increased in early stages of Alzheimer’s disease
- (2020) Niklas Mattsson-Carlgren et al. BRAIN
- Sex-dependent effect of APOE on Alzheimer's disease and other age-related neurodegenerative disorders
- (2020) Julia Gamache et al. Disease Models & Mechanisms
- Neurofilament light as an outcome predictor after cardiac arrest: a post hoc analysis of the COMACARE trial
- (2020) Lauri Wihersaari et al. INTENSIVE CARE MEDICINE
- Serum Glial Fibrillary Acidic Protein (GFAP) Is a Marker of Disease Severity in Frontotemporal Lobar Degeneration
- (2020) Alberto Benussi et al. JOURNAL OF ALZHEIMERS DISEASE
- Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative
- (2020) Thomas K. Karikari et al. MOLECULAR PSYCHIATRY
- Evaluation of a novel immunoassay to detect p-Tau Thr127 in the CSF to distinguish Alzheimer disease from other dementias
- (2020) Jozef Hanes et al. NEUROLOGY
- Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology
- (2020) Inge M. W. Verberk et al. Alzheimers Research & Therapy
- Head‐to‐head comparison of clinical performance of CSF phospho‐tau T181 and T217 biomarkers for Alzheimer's disease diagnosis
- (2020) Thomas K. Karikari et al. Alzheimers & Dementia
- Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration
- (2019) Nicholas J. Ashton et al. Acta Neuropathologica Communications
- A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer’s disease
- (2019) Nicholas J. Ashton et al. Science Advances
- Assessment of Plasma Total Tau Level as a Predictive Biomarker for Dementia and Related Endophenotypes
- (2019) Matthew P. Pase et al. JAMA Neurology
- Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer’s disease
- (2019) Carla M. Startin et al. Alzheimers Research & Therapy
- Subtyping of circulating exosome-bound amyloid β reflects brain plaque deposition
- (2019) Carine Z. J. Lim et al. Nature Communications
- Elecsys® Total-Tau and Phospho-Tau (181P) CSF assays: Analytical performance of the novel, fully automated immunoassays for quantification of tau proteins in human cerebrospinal fluid
- (2019) Valeria Lifke et al. CLINICAL BIOCHEMISTRY
- Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease
- (2019) Niklas Mattsson et al. JAMA Neurology
- Towards a unified protocol for handling of CSF before β-amyloid measurements
- (2019) Shorena Janelidze et al. Alzheimers Research & Therapy
- Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease–Related β-Amyloid Status
- (2019) Sebastian Palmqvist et al. JAMA Neurology
- Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
- (2019) Sebastian Palmqvist et al. EMBO Molecular Medicine
- Clinical validation of the Lumipulse G cerebrospinal fluid assays for routine diagnosis of Alzheimer’s disease
- (2019) Maria João Leitão et al. Alzheimers Research & Therapy
- Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography
- (2018) Michelle M. Mielke et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Update on biomarkers for amyloid pathology in Alzheimer's disease
- (2018) Nicholas J Ashton et al. Biomarkers in Medicine
- Burden of high blood pressure as a contributing factor to stroke in the Japanese community-based diabetic population
- (2018) Ryosuke Komi et al. HYPERTENSION RESEARCH
- A Decade of Blood Biomarkers for Alzheimer’s Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication
- (2018) Liu Shi et al. JOURNAL OF ALZHEIMERS DISEASE
- Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer’s Disease
- (2018) Che-Chuan Yang et al. JOURNAL OF ALZHEIMERS DISEASE
- High performance plasma amyloid-β biomarkers for Alzheimer’s disease
- (2018) Akinori Nakamura et al. NATURE
- No association of salivary total tau concentration with Alzheimer's disease
- (2018) Nicholas J. Ashton et al. NEUROBIOLOGY OF AGING
- Tau Kinetics in Neurons and the Human Central Nervous System
- (2018) Chihiro Sato et al. NEURON
- High salt intake increases plasma trimethylamine N-oxide (TMAO) concentration and produces gut dysbiosis in rats
- (2018) Klaudia Bielinska et al. NUTRITION
- Plasma Biomarkers Differentiate Parkinson’s Disease From Atypical Parkinsonism Syndromes
- (2018) Chin-Hsien Lin et al. Frontiers in Aging Neuroscience
- Association of Changes in Plasma Neurofilament Light and Tau Levels With Anesthesia and Surgery
- (2018) Lisbeth Evered et al. JAMA Neurology
- Plasma amyloid as pre-screener for the earliest Alzheimer's pathological changes
- (2018) Inge M.W. Verberk et al. ANNALS OF NEUROLOGY
- Meta-Analysis of Plasma Amyloid-β levels in Alzheimer's Disease
- (2018) Fei Song et al. JOURNAL OF ALZHEIMERS DISEASE
- Biomarkers for Alzheimer's disease: current status and prospects for the future
- (2018) K. Blennow et al. JOURNAL OF INTERNAL MEDICINE
- Aging and APOE-ε4 are determinative factors of plasma Aβ 42 levels
- (2018) Takumi Nakamura et al. Annals of Clinical and Translational Neurology
- Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease
- (2018) Claudia Cicognola et al. ACTA NEUROPATHOLOGICA
- Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer's disease
- (2018) Zhicheng Chen et al. Alzheimers & Dementia
- Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [18F]-Flutemetamol PET Scan Result
- (2018) Sarah Westwood et al. Frontiers in Aging Neuroscience
- Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and down syndrome
- (2017) Harutsugu Tatebe et al. Molecular Neurodegeneration
- Cryo-EM structures of tau filaments from Alzheimer’s disease
- (2017) Anthony W. P. Fitzpatrick et al. NATURE
- The biomarker-based diagnosis of Alzheimer's disease. 2—lessons from oncology
- (2017) Marina Boccardi et al. NEUROBIOLOGY OF AGING
- Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework
- (2017) Valentina Garibotto et al. NEUROBIOLOGY OF AGING
- Biomarkers for the diagnosis of Alzheimer's disease in clinical practice: an Italian intersocietal roadmap
- (2017) Giovanni B. Frisoni et al. NEUROBIOLOGY OF AGING
- Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework
- (2017) Konstantinos Chiotis et al. NEUROBIOLOGY OF AGING
- Clinical validity of delayed recall tests as a gateway biomarker for Alzheimer's disease in the context of a structured 5-phase development framework
- (2017) Chiara Cerami et al. NEUROBIOLOGY OF AGING
- Clinical validity of medial temporal atrophy as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework
- (2017) Mara ten Kate et al. NEUROBIOLOGY OF AGING
- Association between cerebrospinal fluid and plasma neurodegeneration biomarkers with brain atrophy in Alzheimer's disease
- (2017) Joana B. Pereira et al. NEUROBIOLOGY OF AGING
- Clinical validity of presynaptic dopaminergic imaging with 123 I-ioflupane and noradrenergic imaging with 123 I-MIBG in the differential diagnosis between Alzheimer's disease and dementia with Lewy bodies in the context of a structured 5-phase development framework
- (2017) Ida Sonni et al. NEUROBIOLOGY OF AGING
- Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework
- (2017) Niklas Mattsson et al. NEUROBIOLOGY OF AGING
- Associations between [18F]AV1451 tau PET and CSF measures of tau pathology in a clinical sample
- (2017) Renaud La Joie et al. NEUROLOGY
- Blood-based NfL
- (2017) Oskar Hansson et al. NEUROLOGY
- Factors that influence the levels of cerebrospinal fluid biomarkers in memory clinic patients
- (2017) Anne-Brita Knapskog et al. BMC Geriatrics
- Concordance Between Different Amyloid Immunoassays and Visual Amyloid Positron Emission Tomographic Assessment
- (2017) Shorena Janelidze et al. JAMA Neurology
- Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
- (2017) Niklas Mattsson et al. JAMA Neurology
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- Plasma tau in Alzheimer disease
- (2016) Niklas Mattsson et al. NEUROLOGY
- Plasma β-amyloid in Alzheimer’s disease and vascular disease
- (2016) Shorena Janelidze et al. Scientific Reports
- Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research
- (2015) Sid E. O'Bryant et al. Alzheimers & Dementia
- Cerebrospinal Fluid P-Tau181P: Biomarker for Improved Differential Dementia Diagnosis
- (2015) Hanne Struyfs et al. Frontiers in Neurology
- Plasma Aβ but Not Tau is Related to Brain PiB Retention in Early Alzheimer’s Disease
- (2014) Kai-Yuan Tzen et al. ACS Chemical Neuroscience
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- Plasma phospholipids identify antecedent memory impairment in older adults
- (2014) Mark Mapstone et al. NATURE MEDICINE
- The amyloid-β degradation pattern in plasma—A possible tool for clinical trials in Alzheimer's disease
- (2014) Josef Pannee et al. NEUROSCIENCE LETTERS
- Novel plasma biomarker surrogating cerebral amyloid deposition
- (2014) Naoki KANEKO et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Blood Biomarkers for Brain Injury in Concussed Professional Ice Hockey Players
- (2014) Pashtun Shahim et al. JAMA Neurology
- Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNI
- (2013) Jon B. Toledo et al. ACTA NEUROPATHOLOGICA
- Plasma tau levels in Alzheimer's disease
- (2013) Henrik Zetterberg et al. Alzheimers Research & Therapy
- Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010
- (2012) Thomas G. Beach et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
- (2012) Randall J. Bateman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tau proteins in serum predict neurological outcome after hypoxic brain injury from cardiac arrest: Results of a pilot study
- (2012) Jeffrey Randall et al. RESUSCITATION
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- Amyloid Precursor Protein Processing and Alzheimer's Disease
- (2011) Richard J. O'Brien et al. Annual Review of Neuroscience
- Use of Florbetapir-PET for Imaging β-Amyloid Pathology
- (2011) Christopher M. Clark JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Hypoxia Due to Cardiac Arrest Induces a Time-Dependent Increase in Serum Amyloid β Levels in Humans
- (2011) Henrik Zetterberg et al. PLoS One
- Accumulation of Aspartic Acid421- and Glutamic Acid391-Cleaved Tau in Neurofibrillary Tangles Correlates With Progression in Alzheimer Disease
- (2009) Gustavo Basurto-Islas et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment
- (2008) Clifford R. Jack et al. BRAIN
- Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
- (2008) Milos D. Ikonomovic et al. BRAIN
- Evaluation of plasma Aβ40 and Aβ42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment
- (2008) Oskar Hansson et al. NEUROBIOLOGY OF AGING
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now